|
January 1, 2012 |
| 23:05 EDT |  | TEVA | |
|
December 29, 2011 |
| 11:39 EDT |  | TEVA | | theflyonthewall.com: | Teva releases generic version of HIV drug in U.S., Bloomberg reports | | A Teva (TEVA) spokesperson confirmed that the company commenced shipping the generic version of GlaxoSmithKline's (GSK) Combivir on December 27. A Clal Finance Brokerage analyst said he believes the drug will "generate between 2c-3c in EPS in the next 180 days." Reference Link :theflyonthewall.com |
|
| 10:53 EDT | | TEVA | |
|
December 22, 2011 |
| 08:01 EDT |  | TEVA | | theflyonthewall.com: | Teva guidance for 2012 likely conservative, says Collins Stewart | | Collins Stewart believes Teva's guidance for 2012 is conservative and expects improved earnings visibility to drive shares higher. The firm keeps a Buy rating on the stock with a $65 price target. :theflyonthewall.com |
|
| 07:34 EDT | | TEVA | | theflyonthewall.com: | Teva announces CEO transition | | Teva Pharmaceutical Industries announced that Rob Koremans, has been appointed President and CEO, Teva Europe and will join the company in March 2012. Koremans joins Teva after serving as CEO for Zentiva and most recently Senior VP Generic Strategy and Development at Sanofi-Aventis. After six intensive years, Gerard van Odijk, Teva Europe's current President and CEO has decided to step down. In the next few months, Koremans and van Odijk will work closely together to ensure a smooth transition. van Odijk will remain with Teva to support the EU region for the remainder of 2012. :theflyonthewall.com |
|
|
December 21, 2011 |
| 14:05 EDT | | TEVA | | theflyonthewall.com: | Teva 2012 EPS estimate lowered at Wells Fargo | | After Teva provided weaker than expected 2012 guidance, Wells reduced its 2012 EPS estimate for the company to $5.60 from $5.74. However, the firm expects the company to meet its revised guidance and it continues to view Teva as the best generic pharmaceutical company. The firm maintains an Outperform rating. :theflyonthewall.com |
|
| 09:16 EDT |  | TEVA | |
| 09:02 EDT | | TEVA | | theflyonthewall.com: | Teva: "We can assume that we will continue to increase the dividend" | | :theflyonthewall.com |
|
| 08:59 EDT |  | TEVA | |
| 08:59 EDT | | TEVA | |
| 08:50 EDT | | TEVA | |
| 08:49 EDT | | TEVA | |
| 08:48 EDT | | TEVA | |
| 08:48 EDT | | TEVA | |
| 08:44 EDT | | TEVA | |
| 08:40 EDT | | TEVA | |
| 08:40 EDT | | TEVA | | theflyonthewall.com: | Teva says sees 2012 as a "pivotal" year | | Expects to grow faster than the market in 2012. :theflyonthewall.com |
|
| 08:39 EDT | | TEVA | |
| 08:39 EDT | | TEVA | | theflyonthewall.com: | Teva sees FY12 EPS $5.48-$5.68 vs. consensus $5.67 | | Comments made on its 2012 Business Outlook Conference Call. :theflyonthewall.com |
|
| 07:31 EDT | | TEVA | |
| 07:30 EDT | | TEVA | | theflyonthewall.com: | Teva announces $3B share repurchase program | | :theflyonthewall.com |
|
| 07:06 EDT | | TEVA | |
Source: http://www.theflyonthewall.com/permalinks/entry.php/TEVAid1551458/TEVA-Teva-president-and-CEO-to-retire
graham spanier penn state board of trustees joe pa joe pa brett ratner jerry sandusky toyota recall
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.